Corvus Pharmaceuticals

Price & Volume

Stats

52W Range	$1.30-$10
Market Cap	$302.6M
Shares Short	5M

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$0.99

News

Yahoo Finance • 14 hours ago

Corvus Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference

Yahoo Finance • 3 days ago

Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

Yahoo Finance • 8 days ago

Corvus Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial of Soquelitinib for Patients with Autoimmune Lymphoproliferative Syndrome (ALPS)

Yahoo Finance • last year

Corvus Pharmaceuticals to Present New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition

About

CEO	Dr. Richard A. Miller M.D.
Address	863 Mitten Road, Burlingame, CA, United States, 94010
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	28